ArticleInfectious diseases and therapy2023

Safety and Effectiveness of Regdanvimab for COVID-19 Treatment: A Phase 4 Post-marketing Surveillance Study Conducted in South Korea.

Ji Yeon Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.